Eton Pharmaceuticals Inc. Common Stock (ETON)

About ETON

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate syn…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

44

Website

etonpharma.com/

Fundamentals

1-day range

$58.33$62.12

Market cap

$1.24B

P/E (trailing)

150.92

P/E (forward)

23.17

EPS (trailing)

$-0.06

Dividend yield

—

Beta

0.91

Avg. volume

535.6K

Forecasts

4 analyst ratings

Eton Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ETON

  Eton Pharmaceuticals Inc. Common Stock

  $59.79

  ▼ 4.60%
  Market cap $1.24BP/E 150.92
  $14.27$66.37
• ARDX

  Ardelyx Inc. Common Stock

  $3.81

  ▼ 0.26%
  Market cap $1.23BP/E —
  $3.73$8.4
• LBRX

  LB Pharmaceuticals Inc Common Stock

  $47.8

  ▼ 0.20%
  Market cap $1.23BP/E —
  $13.36$50.16
• MNKD

  MannKind Corporation Common Stock

  $3.96

  ▼ 2.59%
  Market cap $1.21BP/E —
  $2.23$6.51
• SDGR

  Schrodinger Inc. Common Stock

  $19.7

  ▼ 3.48%
  Market cap $1.14BP/E —
  $10.95$23.02
• CRVS

  Corvus Pharmaceuticals Inc. Common Stock

  $14.15

  ▼ 3.87%
  Market cap $1.12BP/E —
  $5.28$26.95
• AVBP

  ArriVent BioPharma Inc. Common Stock

  $30.19

  ▼ 2.63%
  Market cap $1.38BP/E —
  $17$35.83

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
  Benzinga · 8/27/2026
• Insider Unloading: David Krempa Sells Options, Realizes $1.43M
  Benzinga · 8/25/2026
• SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock
  Benzinga · 8/21/2026
• Dow Falls Over 100 Points, Records Weekly Loss: Investor Sentiment Weakens, but Fear Index Remains in ‘Greed’ Zone
  benzinga · 8/17/2026
• Dow Falls Over 100 Points, Records Weekly Loss: Investor Sentiment Weakens, but Fear Index Remains in ‘Greed’ Zone
  Benzinga · 8/17/2026
• Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
  ChartMill · 8/14/2026
• Keep an eye on the top gainers and losers in Friday's session.
  ChartMill · 8/14/2026
• Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68
  Benzinga · 8/14/2026
• Friday's session: gap up and gap down stocks
  ChartMill · 8/14/2026

• MAIER PAUL V · August 28, 2026 · Option Exercise

  50.0K @ $3.78
• MAIER PAUL V · August 28, 2026 · Sale

  128 @ $61.77
• MAIER PAUL V · August 28, 2026 · Sale

  13.5K @ $60.21
• MAIER PAUL V · August 28, 2026 · Sale

  36.4K @ $58.64
• Krempa David · August 24, 2026 · Option Exercise

  25.0K @ $7.31
• Krempa David · August 24, 2026 · Sale

  25.0K @ $65.07
• Matthews Judith M. · July 31, 2026 · Grant

  32.2K
• Erdogan-Trinkaus Ipek · July 31, 2026 · Grant

  80.0K
• Krempa David · July 31, 2026 · Grant

  129.0K
• Adams Jennifer McKie · July 31, 2026 · Grant

  10.0K
• BRYNJELSEN SEAN · July 31, 2026 · Grant

  129.0K
• MAIER PAUL V · July 31, 2026 · Grant

  10.0K
• Norbert G. Riedel · July 31, 2026 · Grant

  10.0K
• Charles J. Casamento · July 31, 2026 · Grant

  10.0K
• Opaleye Management Inc. · July 14, 2026 · Sale

  13.3K @ $37.54

Institutional Ownership

March 31, 2026

Total shares held

17.52M

Total value held

$421.69M

Institutional holders

112